Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Sell
2,905
-344
-11% -$39.7K 0.07% 323
2025
Q4
$342K Sell
3,249
-1,566
-33% -$147K 0.07% 296
2025
Q3
$408K Sell
4,815
-4,551
-49% -$375K 0.09% 234
2025
Q2
$744K Sell
9,366
-54,349
-85% -$4.32M 0.14% 153
2025
Q1
$4.8M Buy
63,715
+49,137
+337% +$4.59M 0.27% 89
2024
Q4
$1.39M Buy
+14,578
New +$1.5M 0.37% 64

Other funds holding MRK

GWN Securities's MRK Position: Q1 2026 in Review

GWN Securities reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $39.7K and leaving 2,905 shares worth $350K. The position accounts for 0.07% of the portfolio, ranked #323.

GWN Securities first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.8M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GWN Securities held 2,905 shares of Merck worth $350K as of Q1 2026.
  • GWN Securities sold 344 Merck shares in Q1 2026, an estimated $39.7K.
  • Merck made up 0.07% of GWN Securities's portfolio in Q1 2026, its #323 holding.
  • GWN Securities first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • GWN Securities's Merck position peaked at $4.8M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GWN Securities's 13F filing for Q1 2026, filed 15 May 2026.